Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

mHealth adoption varies by therapy area

Cystic fibrosis patients most likely to be mobile health users, says survey

mHealth (mobile health)Patients' mobile health adoption, activities and attitudes vary greatly among different therapy areas, according to a new survey.

Manhattan Research found patients with cystic fibrosis were the online audience segments most likely to be mHealth users, followed by those with growth hormone deficiency and then acne.

The consultants said the research highlights the need for marketers to work to understand mobile behaviour by different therapeutic segments.

The Cybercitizen Health study also put the US mobile health audience at 95 million adults in 2013, a 27 per cent year-on-year increase from 2012 when the figure stood at 75 million.

Top 10 mobile health user groups by therapy area:

1. Cystic fibrosis patients

2. Growth hormone deficiency patients

3. Acne patients

4. ADD/ADHD patients

5. Hepatitis C patients

6. Migraine patients

7. Crohn's disease patients

8. Chronic kidney disease patients

9. Generalised anxiety disorder patients

10. Bipolar disorder patients

The study involved over 8,600 US adults being quizzed online and on the phone in Q3 2013 and the above listing is based on online adults in therapy areas with at least 50 respondents.

11th November 2013

From: Marketing, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS Just::

HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics